Literature DB >> 35001174

Discrete field potentials produced by coherent activation of spinal dorsal horn neurons.

Enrique Contreras-Hernández1, Diógenes Chávez1, Edson Hernández1, Pablo Rudomin2,3.   

Abstract

In addition to the action potentials generated by the ongoing activation of single dorsal horn neurons in the anesthetized cat, we often recorded small negative field potentials with a fast-rising phase and a slow decay (dIFPs). These potentials could be separated in different classes, each with a specific and rather constant shape and amplitude. They were largest in spinal laminae III-V and gradually faded at deeper locations, without showing the polarity reversal displayed at these depths by the focal potentials produced by stimulation of muscle and cutaneous afferents. We propose that the dIFPs are postsynaptic field potentials generated by strongly coupled sets of dorsal horn neurons displaying a spatial orientation that generates closed field potentials in response to stimulation of high-threshold cutaneous and muscle afferents. These neuronal sets could form part of the spinal inhibitory circuitry that mediates presynaptic inhibition and Ib non-reciprocal postsynaptic inhibition and could be involved in the sensory-motor transformations activated by stimulation of high-threshold cutaneous afferents.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Dorsal horn; Intraspinal field potentials; Presynaptic inhibition; Spinal cord

Mesh:

Year:  2022        PMID: 35001174     DOI: 10.1007/s00221-021-06286-3

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  61 in total

1.  Unitary inhibitory field potentials in the CA3 region of rat hippocampus.

Authors:  Michaël Bazelot; Céline Dinocourt; Ivan Cohen; Richard Miles
Journal:  J Physiol       Date:  2010-04-19       Impact factor: 5.182

Review 2.  Combining modules for movement.

Authors:  E Bizzi; V C K Cheung; A d'Avella; P Saltiel; M Tresch
Journal:  Brain Res Rev       Date:  2007-09-05

3.  Excitatory and inhibitory intermediate zone interneurons in pathways from feline group I and II afferents: differences in axonal projections and input.

Authors:  B A Bannatyne; T T Liu; I Hammar; K Stecina; E Jankowska; D J Maxwell
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

4.  Gate control of mechanical itch by a subpopulation of spinal cord interneurons.

Authors:  Steeve Bourane; Bo Duan; Stephanie C Koch; Antoine Dalet; Olivier Britz; Lidia Garcia-Campmany; Euiseok Kim; Longzhen Cheng; Anirvan Ghosh; Qiufu Ma; Martyn Goulding
Journal:  Science       Date:  2015-10-30       Impact factor: 47.728

5.  The dorsal horn of the spinal cord.

Authors:  A G Brown
Journal:  Q J Exp Physiol       Date:  1982-04

6.  Requirement of neuronal connexin36 in pathways mediating presynaptic inhibition of primary afferents in functionally mature mouse spinal cord.

Authors:  Wendy Bautista; James I Nagy; Yue Dai; David A McCrea
Journal:  J Physiol       Date:  2012-05-21       Impact factor: 5.182

7.  Circuits for grasping: spinal dI3 interneurons mediate cutaneous control of motor behavior.

Authors:  Tuan V Bui; Turgay Akay; Osama Loubani; Thomas S Hnasko; Thomas M Jessell; Robert M Brownstone
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

8.  Comparison of effects of monoamines on transmission in spinal pathways from group I and II muscle afferents in the cat.

Authors:  H Bras; P Cavallari; E Jankowska; D McCrea
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

9.  Single CA3 pyramidal cells trigger sharp waves in vitro by exciting interneurones.

Authors:  Michaël Bazelot; Maria T Teleńczuk; Richard Miles
Journal:  J Physiol       Date:  2016-02-09       Impact factor: 5.182

10.  Recurrent excitation between motoneurones propagates across segments and is purely glutamatergic.

Authors:  Gardave S Bhumbra; Marco Beato
Journal:  PLoS Biol       Date:  2018-03-14       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.